fda glp-1 warning news november 2025 Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the Adverse Event Reporting System FDA warns Novo Nordisk of

dba iVisitDocJulyMDLas Villas Health Care LLC dba Villas HealthLean Dreams LLC dba LeanDreamsLovely Meds, Inc

Early-phase clinical trial data, including results from a Phase 2 trial published in the New England Journal of Medicine in 2023, demonstrated mean weight loss of up to approximately 24% of baseline body weight at 48 weeks in adults with obesity who did not have type 2 diabetes

GIP receptor signaling increases cAMP levels in the brain, which activates PKA and EPAC [102]

Goldstein J, Kirwin J, Seymour N, Trachtenberg J, Rademaker E, Andersen D

In rodent experiments, GLP-1 receptor activity within the hypothalamus was associated with changes in TSH (thyroid-stimulating hormone) secretion and downstream thyroid hormone regulation